News Story

GlobeImmune Announces Improves HCV End of Treatment Response in Phase 2b

4/19/2010

GlobeImmune

Home | Our Story | Our Portfolio | Our Team | News | Contact Us

Copyright © 2010 Lilly Ventures Management Company, LLC. All rights reserved.